Tissue study to facilitate research into inflammatory bowel disorders

  • Research type

    Research Study

  • Full title

    Human Tissue Study to Investigate Biomarkers in Inflammatory Bowel Disease

  • IRAS ID

    155024

  • Contact name

    Alexandra Belson

  • Contact email

    alex.s.belson@gsk.com

  • Duration of Study in the UK

    9 years, 11 months, 27 days

  • Research summary

    IBD is a chronic inflammatory disorder, with a significant unmet need in terms of treatment. In order to better understand the disease, and develop new therapies for treatment, researchers require access to tissue from patients with IBD, as well as healthy control tissue. This is therefore a collaborative tissue acquisition study to acquire bowel tissue by endoscopy/biopsy and peripheral blood, primarily for identification and evaluation of novel molecular targets and biomarkers involved in IBD.

  • REC name

    East Midlands - Leicester Central Research Ethics Committee

  • REC reference

    15/EM/0042

  • Date of REC Opinion

    4 Feb 2015

  • REC opinion

    Further Information Favourable Opinion